July 2020

At USA PEPTIDE SCIENCES, every blend batch is subjected to comprehensive multi-component quality assessment: HPLC (High-Performance Liquid Chromatography): Independent chromatographic verification of all three active peptide components Tesamorelin, CJC-1295 (No DAC), and Ipamorelin confirming individual purity profiles, blend ratio accuracy, and the complete absence of synthesis impurities or degradation byproducts across all three peptide fractions Mass Spectrometry (MS): Sequential molecular mass verification of each peptide sequence within the finished blend matrix confirming the structural identity of the GHRH(1-44) analog, the tetra-substituted GHRH(1-29) analog, and the GHS-R1a pentapeptide agonist independently Blend Ratio Verification: Analytical confirmation that the relative proportions of all three peptide components within the 12mg blend unit meet specified research-grade formulation standards, ensuring experimental consistency across every vial Endotoxin and Sterility Screening: Applied to all production batches to meet the contamination control standards required in professional preclinical research environments Every 12mg blend unit is released at confirmed 99% purity , with a fully traceable Certificate of Analysis (COA) available through the USA PEPTIDE SCIENCES documentation platform

WADA/USADA Banned Status Both CJC-1295 and Ipamorelin are listed on the World Anti-Doping Agency (WADA) Prohibited List, under the category of Peptide Hormones, Growth Factors, and Related Substances
Conclusion: In summary, the results of the present study show that in FRTL cells, IGF-1 promotes cell cycle progression via an upregulation of cyclin D1 expression, at least partially through the PI3K/NF-B signaling pathway
PI3K/Akt/mTOR Signaling Cascade A primary downstream pathway of IGF-1R activation is the PI3K/Akt/mTOR cascade, which regulates cell survival, protein synthesis, and metabolic homeostasis